In this session, our first presenter will discuss an unique algorithm for selecting compatible platelets for alloimmune refractory patients. The second presenter will review recent research on ABO antibodies and the differential susceptibility of ABO blood groups to COVID-19.
To view Spanish or English subtitles, click the "CC" box in the video player. Para ver subtítulos en español o inglés, haga clic en el cuadro "CC" en el reproductor de video.
Describe the current findings regarding ABO and susceptibility to COVID-19 infection.
Discuss how knowledge of the complexity of ABO antigens and antibodies may help explain differential susceptibility to COVID 19
Compare the platelet donor selection method described in the presentation with the “HLA matching” method for selecting platelet donors for immune refractory patients
All relevant financial relationships have been mitigated. By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
AM21-85: A New Look at Two Familiar Topics: Platelet Transfusion Support for Immune Refractory Patients and the ABO COVID-19 Connection (AABB-ASHI Joint Symposium) Evaluation